Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study
Author:
Affiliation:
1. Center for Clinical Research, Uppsala University, Sörmland, Sweden
2. Department of Surgical Sciences, Uppsala University, Urology, Sweden
3. Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden
Funder
Clinical Research, Sörmland, Uppsala University and Schmekel foundation for Urological research
Publisher
Medical Journals Sweden AB
Subject
Urology,Nephrology
Link
https://www.tandfonline.com/doi/pdf/10.1080/21681805.2022.2062046
Reference11 articles.
1. Long-term Cancer-specific Outcomes of TaG1 Urothelial Carcinoma of the Bladder
2. Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors
3. Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer – is there a long-term survival difference? A Swedish nationwide analysis
4. Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001
5. Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs;Frontiers in Oncology;2023-06-02
2. Reply to Fredrik Liedberg and Johannes Bobjer’s Letter to the Editor re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. NEJM Evid. In press. https://doi.org/10.1056/EVIDoa2200092;European Urology Open Science;2022-12
3. Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. NEJM Evid. In press. https://doi.org/10.1056/EVIDoa2200092;European Urology Open Science;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3